Research Protocols & Grants: Ronney Abaza, MD, FACS


Dr. Abaza's Research Projects

Dr. Abaza has been the primary investigator in the following research projects:
  • A Comparative Study of CO2 Exchange Patterns between Valve-free Trocar (AirSeal) versus Standard Trocar (Endopath®) During Robotic Prostatectomies
  • Retrospective and Prospective Analysis of Robotic Surgery for Renal Tumors
  • Retrospective Analysis of Surgical Outcomes of Upper Tract Robotic Urologic Surgery at The Ohio State University/The James
  • Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The Ohio State University/The James
  • Robotic Prostatectomy without a Catheter Using a Temporary Stent and Fibrin Sealant
  • Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Cystectomy at The Ohio State University/The James
  • A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Microporous Polysaccharide Hemosphere Particles during Robotic Assisted Prostatectomy with Lymph Node Dissection, Under Review
  • Exploratory Retrospective Cost Analysis of Laparoscopic and Robotic Assisted Laparoscopic Nephrectomy at The Ohio State University Medical Center, Under Review
  • Analysis of Technique Comparison with a Vacuum Erection Device as Part of an Erectile Rehabilitation Program Following Robotic Radical Prostatectomy: A Randomized Comparison of Methodology
  • Robotic Surgical Simulator-Based Surgical Curriculum Study (site PI, multi-institutional)
  • Development of an Algorithm for Controlling Vascular Injuries During Laparoscopic Nephrectomy in a Porcine Model; Study ended 2007
  • Intraperitoneal Chemotherapy for the Treatment of Tumor Spillage During Surgery for Wilms’ Tumor; Study ended 2007
  • Retrospective Review of Single Institution Robotic and Open Radical Prostatectomy Perioperative Outcomes; Study ended 2008
  • Impact of Comorbidities on Complications after Primary Radiotherapy for Prostate Cancer; Study ended 2008

Dr. Abaza has been the co-investigator in the following research projects:
  • A Comparison of Tangerine and Red Tomato Juice in Men with Prostate Cancer: A Pilot Study
  • Biomarkers of Prostate and Cardiovascular Health of Men Undergoing Prostatectomy Consuming Different Amounts of Soy-Tomato Juice (PI: Steven Clinton, MD)
  • Imaging of the Prostate Gland Using High Field Strength 3T MRI (PI: Michael Knopp, MD)
  • Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and Ex-Vivo Ultra-High-Field MRI (PI: Michael Knopp, MD)
  • Effects of Deep Trendelenburg Positioning and Anesthesia on Intraocular Pressure and Optic Nerve During Robotic Cystectomies, Prostatectomies, and Hysterectomies (PI: Hamdy Elsayed-Awad)
  • A Retrospective Review of the Effects of Deep Trendelenburg Positioning and Anesthesia on Intraocular Pressure and Optic Nerve During Robotic Cystectomies, Prostatectomies, and Hysterectomies (PI: Hamdy Elsayed-Awad)
  • ALGB 90203: Randomized Phase III Study of Neoadjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer (PI: Paul Monk, MD)
  • A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced RCC Following Nephrectomy (PI: David Sharp, MD)
  • A Phase II and Biomarker Study of Tivozanib in Subjects with Advanced Renal Cell Carcinoma (PI: Robert Bahnson, MD)
  • Open vs Robotic-Assisted Radical Cystectomy: A Randomized Trial (PI: Ahmad Shabsigh)
  • A Multi-Center, Open-Label, Surgical Surveillance Trial to Evaluate the Safety and Efficacy of a Shortened Infusion Time of Intravenous Ibuprofen (PI: Sergio Bergese)—Study Completed 2011
  • A Comparative Study of PET/CT Versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Pre-surgical Patients with Renal Masses Using Iodine-124 labeled Chimeric G250 (PI: Robert Bahnson, MD)—Study Completed 2010
  • Evaluation of the Safety and Efficacy of Computer Enhanced Robotic System (daVinci®) in Infrarenal Aortic Reconstruction for Aneurysmal Disease, FDA Protocol IDE G030039 (PI: Bernardo Martinez, MD); 2006-7
  • A Double-Blind, Randomized, Multiple Dose, Phase III, Multicentre Study of Alpharadin in the Treatment of Patients with Symptomatic Hormone Refractory Prostate Cancer with Skeletal Metastases (PI: Ahmad Shabsigh, MD)

Research Grants

  • Principal Investigator, Surgiquest, Inc.; 3/1/2013–12/31/2013; $100,000
    • A COMPARATIVE STUDY OF CO2 EXCHANGE PATTERNS AND EARLY COGNITIVE RECOVERY BETWEEN VALVE FREE TROCAR (AIRSEAL®) VERSUS STANDARD TROCAR (ENDOPATH®) DURING ROBOTIC PROSTATECTOMIES
  • Principal Investigator, Intuitive Surgical, Inc.; 9/1/2012–12/31/2013; $48,164
    • PREVENTION OF LYMPHOCELES AFTER ROBOTIC EXTENDED PELVIC LYMPH NODE DISSECTIONS FOR UROLOGIC AND GYNECOLOGIC MALIGNANCIES USING THE DA VINCI® ENDOWRIST® ONE™ VESSEL SEALER
  • Principal Investigator, Medafor, Inc.; 8/1/2011–12/31/2013; $60,000
    • A PILOT CLINICAL TRIAL FOR THE PREVENTION OF POSTOPERATIVE LYMPHOCELES USING ABSORBABLE MICORPOROUS POLYSACCHARIDE HEMOSPHERE PARTICLES DURING ROBOTIC ASSISTED PROSTATECTOMY WITH LYMPH NODE DISSECTION
  • Principal Investigator, Timm Medical, Inc.; 9/1/2011–12/31/2013; $8,000
    • ANALYSIS OF TECHNIQUE COMPARISON WITH A VACUUM ERECTION DEVICE AS PART OF AN ERECTILE REHABILITATION PROGRAM FOLLOWING ROBOTIC RADICAL PROSTATECTOMY: A RANDOMIZED COMPARISON OF METHODOLOGY (OSU Protocol #2011C0053)
  • Co-Investigator, Center for Advanced Functional Foods Research and Entrepreneurship pilot grant (P.I. Steven Clinton); 1/15/13-6/1/13; $20,000
    • BLACK RASPBERRIES AND TISSUE BIOMARKERS OF HUMAN PROSTATE CARCINOGENESIS
  • Co-Investigator, Wilex, Inc.  (P.I. Robert Bahnson); completed 7/29/11; $1,500,000
    • WX/20-001: A COMPARATIVE STUDY OF PET/CT VERSUS DIAGNOSTIC CT FOR THE DETECTION OF CLEAR CELL RENAL CELL CARCINOMA IN PRE-SURGICAL PATIENTS WITH RENAL MASSES USING IODINE-124 LABELED CHIMERIC G250 (124I-CG250) (OSU Protocol #2008W0046)
  • Co-Investigator, NCI 1R21CA156945-01A1 (P.I. Guang Jia); 9/1/2011-9/1/2013; $652,876
    • ASSESSMENT OF AMIDE-PROTON-TRANSFER MRI IN PROSTATE CANCER
  • Co-Investigator, Cumberland Pharmaceuticals (P.I. Sergio Bergese); completed 6/27/11; $30,000
    • A MULTI-CENTER, OPEN-LABEL, SURVEILLANCE TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF A SHORTENED INFUSION TIME OF INTRAVENOUS IBUPROFEN (OSU Protocol # 20110029)
  • Co-Investigator, Cumberland Pharmaceuticals (P.I. Sergio Bergese); completed 7/18/11; $30,000
    • A MULTI-CENTER, OPEN-LABEL, SURGICAL SURVEILLANCE TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF A SHORTENED INFUSION TIME OF INTRAVENOUS IBUPROFEN (OSU Protocol # 20110028)
  • Co-Investigator, VEG113387 (P.I. David Sharp); $159,920
    • A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PAZOPANIB AS ADJUVANT THERAPY FOR SUBJECTS WITH LOCALIZED OR LOCALLY ADVANCED RCC FOLLOWING NEPHRECTOMY (OSU Protocol # 2011W0047)
  • Co-Investigator,  (P.I. Robert Bahnson); $12,985
    • A PHASE 2 AND BIOMARKER STUDY OF TIVOZANIB IN SUBJECTS WITH ADVANCED RENAL CELL CARCINOMA (OSU Protocol # 2011W0036)
  • Co-Investigator,  (P.I. Michael Knopp); $3,371,559
    • IMAGING OF BLADDER CANCER USING CLINICAL 3 TESLA MRI AND EX-VIVO ULTRA-HIGH-FIELD MRI (OSU Protocol # 2009C0001)
  • Co-Investigator,  (P.I. Michael Knopp); $3,431,559
    • IMAGING OF THE PROSTATE GLAND USING HIGH FIELD STRENGTH 3T MRI (OSU Protocol # 2007C0048)